Flexion Therapeutics (FLXN)
US Market

Flexion Therapeutics (FLXN) Stock Price & Analysis


FLXN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$4.30 - $13.66
Previous Close$9.12
Average Volume (3M)1.77M
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)-4.6
Next EarningsN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.98
Shares OutstandingN/A
10 Day Avg. Volume3,028,267
30 Day Avg. Volume2,996,453
Standard DeviationN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside17.00% Upside
Rating ConsensusHold
Number of Analyst Covering6

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Flexion Therapeutics’s price range in the past 12 months?
Flexion Therapeutics lowest stock price was $4.30 and its highest was $13.66 in the past 12 months.
    What is Flexion Therapeutics’s market cap?
    Flexion Therapeutics’s market cap is 458.93M.
      When is Flexion Therapeutics’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Flexion Therapeutics’s earnings last quarter?
      Currently, no data Available
      Is Flexion Therapeutics overvalued?
      According to Wall Street analysts Flexion Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Flexion Therapeutics pay dividends?
        Flexion Therapeutics does not currently pay dividends.
        What is Flexion Therapeutics’s EPS estimate?
        Flexion Therapeutics’s EPS estimate is -1.98.
          How many shares outstanding does Flexion Therapeutics have?
          Flexion Therapeutics has 50,320,000 shares outstanding.
            What happened to Flexion Therapeutics’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Flexion Therapeutics?
            Among the largest hedge funds holding Flexion Therapeutics’s share is First Eagle Investment Management LLC. It holds Flexion Therapeutics’s shares valued at 237K.


              Flexion Therapeutics Stock Smart Score

              The Flexion Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              Flexion Therapeutics

              Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand. The company was founded by Michael D. Clayman and Neil Bodick in 2007 and is headquartered in Burlington, MA.


              Forecast EPS vs Actual EPS

              Currently, no data available
              Please return soon. This page is being updated.

              Similar Stocks
              Price & Change
              Ampio Pharmaceuticals
              Radius Health
              Axsome Therapeutics

              Popular Stocks

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis